Eargo (EAR) Stock Price, News & Analysis

Company Overview

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Key Stats

• Today's Range: $70.50 to $70.50
• 50-Day Range: $2.57 to $70.50
• 52-Week Range: $1.47 to $8.48
• Volume: N/A
• Average Volume: 23,347 shs
• Market Capitalization: $1.46 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EAR Stock Analysis - Frequently Asked Questions

How were Eargo's earnings last quarter?

Eargo, Inc. (NASDAQ:EAR) released its quarterly earnings results on Thursday, August, 12th. The company reported ($7.20) EPS for the quarter, missing analysts' consensus estimates of ($5.00) by $2.20. The business had revenue of $22.88 million for the quarter, compared to the consensus estimate of $22.14 million. Eargo had a negative trailing twelve-month return on equity of 135.08% and a negative net margin of 263.14%.

When did Eargo's stock split?

Eargo's stock reverse split before market open on Wednesday, January 18th 2023.The 1-20 reverse split was announced on Wednesday, January 18th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Eargo IPO?

Eargo (EAR) raised $100 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. J.P.Morgan and BofA Securities acted as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers.

What other stocks do shareholders of Eargo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eargo investors own include Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Home Depot (HD).

Company Calendar

• Last Earnings: 8/12/2021
• Today: 7/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:EAR
• CIK: 1719395
• Web: eargo.com
• Phone: 650-351-7700
• Fax: N/A
• Employees: 243
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($7.52)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$157.49 million
• Net Margins: -263.14%
• Pretax Margin: -262.90%
• Return on Equity: -135.08%
• Return on Assets: -96.37%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.22
• Quick Ratio: 2.97

Sales & Book Value

• Annual Sales: $41.11 million
• Price / Sales: 35.61
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.87 per share
• Price / Book: 14.48

Miscellaneous

• Outstanding Shares: 20,762,000
• Free Float: 20,594,000
• Market Cap: $1.46 billion
• Optionable: Not Optionable
• Beta: 1.50